↓ Skip to main content

Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety

Overview of attention for article published in CNS Drugs, February 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
118 Mendeley
Title
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Published in
CNS Drugs, February 2020
DOI 10.1007/s40263-020-00708-6
Pubmed ID
Authors

Simona Lattanzi, Francesco Brigo, Eugen Trinka, Gaetano Zaccara, Pasquale Striano, Cinzia Del Giovane, Mauro Silvestrini

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 118 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 17%
Student > Bachelor 14 12%
Other 11 9%
Student > Master 10 8%
Professor 6 5%
Other 18 15%
Unknown 39 33%
Readers by discipline Count As %
Medicine and Dentistry 27 23%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Neuroscience 10 8%
Nursing and Health Professions 6 5%
Biochemistry, Genetics and Molecular Biology 5 4%
Other 13 11%
Unknown 47 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2020.
All research outputs
#14,473,576
of 23,192,960 outputs
Outputs from CNS Drugs
#1,042
of 1,319 outputs
Outputs of similar age
#243,142
of 455,714 outputs
Outputs of similar age from CNS Drugs
#18
of 26 outputs
Altmetric has tracked 23,192,960 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,319 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,714 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.